← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

M

$ Value

$0

Shares

285

Price

$0

Filed

Dec 18

Insider

Name

Espinoza Octavio

Title

Chief Financial Officer

CIK

0001905248

Roles

Officer

Transaction Details

Transaction Date

2025-12-16

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

18,171

Footnotes

The stock option vests as to approximately 55% of the underlying shares in 12 substantially equal monthly installments beginning on January 5, 2025, and approximately 45% of the underlying shares in two substantially equal monthly installments thereafter. | As per the separation of OmniAb Inc. from the issuer, 4,096 stock options were vested and exercisable as of November 1, 2022, whereas 3,766 options vest in 23 substantially equal monthly installments beginning on December 1, 2022. | Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter. | The stock option is fully vested and exercisable. | The stock option vests as to 50% of the underlying shares on January 3, 2025 and as to the remaining on February 3, 2025.

Filing Info

Accession No.

0002001011-25-000127

Form Type

4

Issuer CIK

0000886163

Espinoza Octavio's History

Date Ticker Type Value
2026-03-02 LGND A $0
2026-03-02 LGND A $0
2025-12-31 LGND J $765
2025-12-16 LGND M $63K
2025-12-16 LGND M $4K
2025-12-16 LGND M $18K
2025-12-16 LGND M $60K
2025-12-16 LGND M $19K
2025-12-16 LGND M $0
2025-12-16 LGND M $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01